Leukemia, Prolymphocytic - 23 Studies Found

Terminated : Lenalidomide With or Without Rituximab in Treating Patients With Progressive or Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Prolymphocytic Leukemia, or Non-Hodgkin Lymphoma Previously Treated With Donor Stem Cell Transplant
:
  • Adult Nasal Type Extranodal NK/T-cell Lymphoma
  • Anaplastic Large Cell Lymphoma
  • : 2011-08-15
    :
    • Drug: lenalidomide Given PO
Active, not recruiting : Romidepsin Maintenance After Allogeneic Stem Cell Transplantation
:
  • Cutaneous T-cell Lymphoma
  • T-Prolymphocytic Leukemia
  • : 2015-07-29
    :
    • Drug: Romidepsin

Completed : Safety and Dose Study of GRN163L to Treat Patients With Chronic Lymphoproliferative Disease(CLD)
: Chronic Lymphoproliferative Diseases
: 2005-07-25
: Drug: GRN163L Weekly intravenous infusion
<<< Previous